The goal of our study was to apply a network analysis to patient-derived CD4+ T cell methylation profiles to discover novel potential pathogenic mechanisms in patients with PAH at time of diagnosis or early follow-up. The gene discussed is CD4; the disease is pulmonary arterial hypertension.